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Warfarin-Induced Penile Necrosis in a Patient with  
Heparin-Induced Thrombocytopenia
A 56-yr-old man with lung adenocarcinoma presented with subsegmental pulmonary 
thrombosis. Platelet count on presentation was 531×10
9/L. The patient was anticoagulated 
with subcutaneous low molecular weight heparin (LMWH). Next day, oral anticoagulation 
was initiated with 5 mg of warfarin once daily with LMWH and LMWH was discontinued at 
third hospital day. On the third day of oral anticoagulation therapy, he complained of left 
leg swelling and prolonged painful penile erection of 24 hr-duration. His platelet count 
reached a nadir 164×10
9/L at that time, and the patient had a deficiency of protein C and S, 
with an activity level of 16% and 20% of normal value. Warfarin was stopped and he 
underwent penile aspiration. The next day, left leg edema and penile erection was 
disappeared, but penile and glans penis necrosis was started. This case illustrates that 
processes underlying heparin-induced thrombocytopenia (HIT) may also underlie warfarin-
induced skin necrosis. 
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Urology
INTRODUCTION
Penile necrosis is a rare but serious side effect of treatment with 
warfarin. A number of penile and skin necrosis cases have been 
reported in association with a familial or acquired deficiency of 
protein C and protein S (1-3). As initially determined in patients 
with hereditary thrombophilia, the proposed theoretical mech-
anism of warfarin-induced skin necrosis (WISN) is that necrosis 
occurs during a transient prothrombotic state due to the short 
half-life of the natural anticoagulant protein C (half-life 6 hr) com-
pared to the half-life of the major procoagulant factor prothrom-
bin (half-life 72 hr) (4-6). Despite this proposed mechanism, 
most patients with WISN have no identifiable hereditary hyper-
coagulable state. Given the frequent concomitant use of heparin 
products during warfarin initiation and the increasing recogni-
tion of heparin-induced thrombocytopenia (HIT) as an acquired 
hypercoagulable state, we believe that unrecognized HIT may 
underlie many cases of WISN. 
  In this report we describe a patient who developed profound 
necrotic penile lesions in the hypercoagulable mileu of meta-
static adenocarcinoma and HIT while receiving systemic anti-
coagulation with low molecular weight heparin and warfarin. 
CASE REPORT
A 56-yr-old man with lung adenocarcinoma presented with sub-
segmental pulmonary thrombosis on April 27 2009. At the time 
of the first general physical examination the disease was at an 
inoperable stage due to multiple bone metastases. The CT scan 
of lungs revealed thrombosis of subsegmental and lobar pul-
monary arteries within the right lung and left lower lobe. The 
platelet count on presentation was 531×10
9/L. After the diagno-
sis was made, the patient was started on anticoagulation with 
subcutaneous low molecular weight heparin (LMWH, Enoxa-
parin sodium, CLEXANE
®) 50 mg twice daily. The next day, oral 
anticoagulation was initiated with 5 mg of warfarin once daily; 
the LMWH was discontinued on the third hospital day. On the 
third day of oral anticoagulation therapy, the patient complained 
of left leg swelling and a prolonged painful penile erection of 24 
hr-duration. In addition, he was unable to void and required ure-
thral catheterization to empty his bladder. The platelet count 
reached a nadir of 164×10
9/L at that time. There was no familial 
history of thrombophilia (Fig. 1). Physical examination revealed 
a cachectic, anxious, and severely ill man. The left lower limb 
was swollen, tender, and warm with tense shiny skin. There was 
a 13-cm difference between the circumference of the right and 
the left limbs above and below the knees. The penis was mark-
edly engorged and extremely tender. 
  A complete blood count showed that the hemoglobin was 5.4 g, 
hematocrit 16.7% and the white blood cell count was 15,990 (neu-
trophils 87.9%, lymphocytes: 5.6%, monocytes: 5.1%, eosinophils: 
1.3%, basophils: 0.1%). The prothrombin time was 61 sec (con-Chang IH, et al.  •  Warfarin Induced Penile Necrosis
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trol: 12.5 sec) and international normalized ratio (INR) was 6.01. 
Doppler sonography of the left leg showed a deep vein throm-
bosis. The warfarin was discontinued and a detailed coagula-
tion pathway analysis including protein C and S levels in the 
sera were performed. The protein C and S levels were assayed 
with functional protein C (Staclot ProteinC kit; Diagnostica Sta-
go, Asniens-Sur-Siene, France) and radial immunodisffusion 
(RID), (Human Protein S ‘NL’ NANORID
TM, RID kit; The Bind-
ing Site Ltd, Birmingham, UK). The results showed that the pa-
tient had a protein C and S deficiency, with an activity level of 
16% and 20% of normal values. 
  The patient was treated with narcotic analgesia in the form of 
10 mg Meperidine HCl (Pethidine) intravenously, and LMWH 
(Enoxaparin sodium) (CLEXANE
®) 50 mg twice daily. He under-
went penile aspiration and blood gas analysis of cavernosal blood 
revealed severe acidosis, suggesting low flow priapism (pH 6.51, 
partial pressure of carbon dioxide 89.8 mmHg). The blood clots 
were extracted and irrigation with normal saline and ephedrine 
was performed. The next day, the left leg edema and penile erec-
tion resolved, but the penile skin became darkly discolored (Fig. 
2A). On the penile Doppler ultrasonography, the penile arterial 
flow was intact. Seven days after the initial event, the physical 
findings showed necrosis of the distal half of the penis includ-
ing the glans penis; a partial penectomy was performed (Fig. 2B). 
The pathology demonstrated hemorrhagic necrosis with orga-
nizing thrombi. Three weeks after the surgery, the patient died 
of complications and progression of the metastatic lung adeno-
carcinoma.
DISCUSSION
Bleeding is the most common complication of warfarin treat-
ment. However, paradoxical thromboembolic events including 
the purple toe syndrome, skin necrosis, purpura fulminans, pri-
apism, and penile necrosis have been reported (7). In early de-
scriptions of WISN, patients demonstrated abnormalities of nat-
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Fig. 1. Serial platelet counts relative to hospital day 
for a patient with metastatic lung adenocarcinoma 
being treated for pulmonary thrombosis and later 
found to develop anticoagulation-induced penile nec-
rosis and HIT. Anticoagulant used per hospital day is 
shown as well. The patient developed priapism and 
penile necrosis by the 3rd days of warfarin admini-
stration. 
Fig. 2. Penile necorsis lesion of a patient receiving systemic anticoagulation with low molecular weight heparin and warfarin. Skin distal half penile shaft and glans penis showed 
black discoloration with erythema after penile blood clot extraction due to priapsm (A). International normalized ratio (INR) at the time of appearance was 6.01 and the platelet 
count was 164×10
9/L. Results showed that the patient had a deficiency of protein C and S, with an activity level of 16% and 20% of normal value. The patient had a known 
diagnosis metastatic lung adenocarcinoma. Seven days after the initial event, physical findings showed distal half penile necrosis including glans penis and we performed partial 
penectomy (B). 
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ural anticoagulant pathways, such as congenital deficiency of 
protein C, protein S, or antithrombin III (3-6). However, as obser-
vations of WISN accumulated, it became clear that many patients 
had no identifiable hereditary hypercoagulable disorder. Srini-
vasan et al. (8) published a series of six patients with known HIT 
that developed either skin necrosis or venous limb gangrene 
during initiation of warfarin therapy. From this case report, it is 
clear that the finding of skin necrosis during systemic anticoag-
ulation with heparin overlapping with warfarin should alert one 
to the possibility of underlying HIT. In the current report, the pe-
nile arterial flow was intact on penile Doppler ultrasonography. 
  The pathogenesis of anticoagulation induced necrotic skin has 
been studied in patients with necrotic skin lesions due to HIT. 
In a series of HIT patients with venous limb gangrene, Warken-
tin et al. (9) reported that patients with HIT that developed ve-
nous limb gangrene were more likely to be receiving warfarin at 
the time of limb ischemia than other HIT patients. In addition, 
these patients had a significantly higher INR at the time of the 
development of gangrene than HIT patients that only had arte-
rial and/or venous thrombotic events. However, despite the el-
evated INRs, these patients had higher levels of thrombin-anti-
thrombin complexes simultaneously. Coagulation factor stud-
ies have revealed that these patients have severe depletion of 
factor VII (the coagulation factor most rapidly affected by vita-
min K antagonists) as well as protein C. These observations sug-
gest that patients with hypercoagulable disorders are predispos-
ed to skin necrosis during anticoagulation administration due 
to an increase in the ratio of thrombin-antithrombin complexes 
to protein C activity (10, 11).
  Penile ischemia and necrosis can be caused by penile pros-
thesis, severe diabetes, thrombotic phenomena and a buildup 
of calcium deposits in patients on dialysis. Acute ischemia of the 
penis is rarely seen because of the excellent collateral circulation 
of the perineum and lower abdomen (12). There are at least three 
mechanisms for acute ischemia of the male genitalia-widespread 
ligation of collateral circulation to the penis, spontaneous em-
bolism and operative embolism (13). Other forms of venous in-
farction can occur from priapism and intracorporeal injection 
of pharmacotherapeutic agents (13). Gradual necrosis has been 
seen with low cardiac output and renal failure (12).
  Priapism is a medical emergency. It is defined as a persistent 
penile erection that continues hours beyond, or is unrelated to, 
sexual stimulation (14). Our patient had no history of trauma or 
neurological disease. Priapism occurred in association with low-
er limb deep vein thrombosis and anticoagulation therapy. Pri-
apism in patients with protein C deficiency alone or in associa-
tion with FV Leiden has been rarely described (15, 16). Antico-
agulants such as heparin, warfarin and acenocoumarol have 
been implicated in the etiology of priapism (16).
  In the current report, the present patient developed penile 
necrosis with priapism that was initially attributed to WISN 
alone. However, the degree of penile necrosis was severe, and 
the patient had relative thrombocytopenia at the time of necro-
sis; we could not rule out HIT in this case. As this patient illus-
trates, clinical evidence of HIT may be evident before the devel-
opment of thrombocytopenia or a 50% relative drop in the plate-
let count. Moreover, our patient had protein C and S deficiency. 
Thus, the patient’s penile skin necrosis can be attributed to the 
underlying hypercoagulable milieu of HIT, warfarin treatment, 
and metastatic adenocarcinoma. As this case illustrates, it may 
be initially unclear whether anticoagulation-induced skin ne-
crosis is due to WISN or a manifestation of a hypercoagulable 
disorder such as HIT. Therefore, HIT should always be consid-
ered in the differential diagnosis of anticoagulation-induced 
skin necrosis given the frequent concomitant administration of 
heparin products with warfarin and the increasing recognition 
of HIT as one of the most common acquired hypercoagulable 
disorders. 
  Treatment of HIT requires anticoagulation with one of two 
classes of anticoagulation agents. Direct thrombin inhibitors or 
heparinoids. Three direct thrombin inhibitors are currently avail-
able for patients with HIT: lepirudin, argatoban, and bivaliru-
din. These agents directly bind and interact with thrombin, and 
unlike heparin, do not require antithrombin. Direct thrombin 
inhibitors have short half-lives and show no cross-reactivity with 
heparin (17). However, we cannot use direct thrombin agents 
or heparnoids, because these agents have not been introduced 
in Korea; therefore, we waited until one day after the platelet 
count reached its nadir and then started LMWH. After treatment 
with the LMWH, the platelet counts increased and reached a 
stable plateau.
  Given the rare, but well-documented risk of cutaneous ne-
crosis during warfarin treatment in patients with HIT, several 
precautions should be undertaken to minimize the risk of skin 
necrosis. First, unopposed warfarin administration should be 
avoided in these patients and adequate levels of an alternative 
anticoagulant should be ensured prior to treatment with warfa-
rin (17). The alternative anticoagulant should not be discontin-
ued until the platelet count reaches a stable plateau and until 
there is at least five days of overlap with the INR>2 for two con-
secutive days (17). In addition, excessive levels of warfarin anti-
coagulation should be avoided in order to prevent a precipitous 
decrease in protein C levels (11). As was mentioned earlier, a 
supertherapeutic INR during warfarin initiation in a thrombo-
philic patient does not necessarily guarantee protection against 
thrombin generation. 
  Because of the early effects on protein C, warfarin can precip-
itate penile necrosis in the extreme hypercoagulable milieu of 
HIT. In patients with HIT, unopposed warfarin should be avoid-
ed. Warfarin should be initiated at modest doses in patients with 
HIT after platelet recovery. Chang IH, et al.  •  Warfarin Induced Penile Necrosis
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